---
created: 2025-04-13
updated: 2025-04-13T10:52
id: d5q6%_NY#=
specialty: cardio
specialty_id: 233
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::05-cardio::08-hypertension::03-antihypertensives
  - "source/ak-step1-v11:": 
  - theme/b&b::19-renal::01-intro::04-physiology-ii
  - "source/ak-step1-v11:": 
  - theme/firstaid::14-renal::05-pharm::08-angiotensin-converting-enzyme-inhibitors
  - "source/ak-step1-v11:": 
  - theme/firstaid::14-renal::05-pharm::09-angiotensin-ii-receptor-blockers
  - "source/ak-step1-v11:": 
  - source/ome-banner::clinical::01-cardiology::08-hypertension
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::06-renal::06-ace-inhibitors
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::06-renal::07-angiotensin-ii-receptor-blockers
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::17-renal::ace-inhibitors
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::17-renal::angiotensin-ii-receptor-blockers-(arbs)
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::02-cardio-&-renal::01-heart-failure-drugs::02-ace-inhibitors,-arbs,-aliskiren
  - "source/ak-step1-v11:": 
  - theme/uworld::100-999::600-699::694
  - "source/ak-step1-v11:": 
  - theme/uworld::100-999::600-699::696
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::cardio::pharmacology
  - source/ak-step1-v11::^systems::renal::pharmacology"
type: flashcard
---

# Question
ACE inhibitors and ARBs primarily cause **dilation** of the **efferent** arteriole of the kidney

---

# Answer
in pts with bilateral renal stenosis, ACE inhibitors (eg, lisinopril) cannot be given; if so == dec renal perfusion + dec intraglomerular P + dec filtration fraction ~ AT II lvl reduction  Remember that AT II vasoconstricts the efferent arteriole to maintain adequate GFR in these pts